Open original FDA record ↗Recall record
- FDA identifier
- Z-0243-2022
- Company in FDA record
- bioMerieux, Inc.
- FDA record creation date
- Nov 17, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is potential to provide an incorrect organism identification.
Source facts
- Action
- Notification letters were issued to customers via FedEx Priority Overnight mail during the week of October 4, 2021. Customers are asked to do the following: -Discontinue use of and discard any remaining inventory of lot 1008679230. -For tests previously performed using API 50 CH Ref. 50300 lot# 1008679230, we are asking you to identify any possible incorrect identification test result due to a false positive reaction of test 34, analyze the related risks and to determine appropriate actions, if relevant. -Complete the Acknowledgement Form in Attachment A and return it to your local bioMrieux representative to confirm receipt of this notice. -Distribute this information to all appropriate personnel in the laboratory, retain a copy in your files. -Contact your local bioMrieux representative for product compensation. Consignees will perform destruction activities at their site.
- Initiated
- 2021-09-30
- Root cause
- Material/Component Contamination
- Terminated
- 2024-01-18
- Distribution
- Distribution in WI, NY, and SD
- Recall number
- Z-0243-2022
- Recall status
- Terminated
- CDRH record ID
- 189710
- FDA record created
- 2021-11-17
- Recall event number
- 88844